Standard whole blood composition for determining the potency of blood clotting inhibitory substances
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 7, 1994
Issued Date -
N/A
app pub date -
Jan 14, 1993
filing date -
Nov 10, 1988
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A standard whole blood composition is disclosed, which is useful as a pooled human hemostasis reference standard in blood coagulation assays including Activated Clotting Time (ACT), Whole Blood Prothrombin Time (WBPT), Whole Blood Activated Partial Thromboplastin Time (WBAPTT) and Whole Blood Thrombin time (WBTT). Also disclosed are methods for determining the human standardized potency of heparin and protamine.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully